380 filings
Page 10 of 19
6-K
BNTX
BioNTech SE
7 Sep 21
Current report (foreign)
6:47am
6-K
BNTX
BioNTech SE
27 Aug 21
Current report (foreign)
8:38am
6-K
BNTX
BioNTech SE
26 Aug 21
Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
8:58am
6-K
BNTX
BioNTech SE
26 Aug 21
Current report (foreign)
12:00am
6-K
BNTX
BioNTech SE
24 Aug 21
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
12:00am
6-K
BNTX
BioNTech SE
17 Aug 21
Pfizer and Biontech Announce Submission of Initial Data to U.S. Fda to Support Booster Dose of COVID-19 Vaccine
12:00am
6-K
BNTX
BioNTech SE
9 Aug 21
Interim Condensed Consolidated Financial Statements
9:06am
6-K
BNTX
BioNTech SE
9 Aug 21
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
8:10am
6-K
BNTX
BioNTech SE
4 Aug 21
BioNTech completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
7:34am
6-K
BNTX
BioNTech SE
26 Jul 21
BioNTech provides update on plans to develop sustainable solutions to address infectious diseases on the African continent
4:42pm
6-K
BNTX
BioNTech SE
23 Jul 21
Dose deliveries for new order expected to occur from October 2021 through April 2022
8:19am
6-K
BNTX
BioNTech SE
9 Jul 21
Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant
8:29am
6-K
BNTX
BioNTech SE
22 Jun 21
Current report (foreign)
4:45pm
6-K
BNTX
BioNTech SE
21 Jun 21
BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
6:53am
6-K
BNTX
BioNTech SE
10 Jun 21
Current report (foreign)
7:32am
6-K
BNTX
BioNTech SE
10 Jun 21
Current report (foreign)
7:22am
6-K
BNTX
BioNTech SE
28 May 21
Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
4:55pm
6-K
BNTX
BioNTech SE
21 May 21
BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG
7:07am
6-K
BNTX
BioNTech SE
20 May 21
Pfizer and BioNTech Sign Agreement
6:51am
6-K
BNTX
BioNTech SE
20 May 21
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses
6:42am